How do you pay?

How to pay the least

Cash price

$3,650+ for 30 tablets

Pharmacies pay about this for Juluca; you’d pay more.

  1. Ask your pharmacy for Juluca’s cash price, and one or two other pharmacies too.
  2. Juluca’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify ViiV Healthcare Patient Assistance Program (PAP). Patients whose income exceeds program eligibility maximum will be provided the opportunity to demonstrate that their eligible medical expenses bring them within the income eligibility criteria (please contact program for details). Or call 1-844-588-3288.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameJuluca
Authorized genericdolutegravir and rilpivirine
Regular genericdolutegravir and rilpivirine
What you’d pay
At least$3,650for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Juluca?
The original
–
–

Brand nameThe maker’s card

ViiVConnect Savings Card (ViiVConnect Copay Program)

Savings card from ViiV Healthcare

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

The card takes up to $6,250 a year off your co-pay.

Sign up on viivconnect.com 

Or call 1-844-588-3288.

In the maker’s words

“Eligible Patients may pay as little as $0 on each prescription fill…”

From the maker’s offer on viivconnect.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Juluca itself, from the same company, sold without the brand name, and usually for less. For now Juluca is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

JULUCA, a two-drug combination of dolutegravir, an HIV-1 integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI), is indicated as a complete regimen for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of JULUCA.

Source: the FDA label for Juluca (ViiV Healthcare Company), October 29, 2025. Full label on DailyMed 

Good to know